Poster preview
ePoster
SERUM <SUP>1</SUP>H-NMR METABOLOMIC PROFILING DISTINGUISHES OCB TYPE 1 AND TYPE 2 PATTERNS IN EARLY POSSIBLE MULTIPLE SCLEROSIS
Pinar Senguland 2 co-authors
Acibadem University
FENS Forum 2026 (2026)
Barcelona, Spain
Board PS03-08AM-009
Presentation
Date TBA
Board: PS03-08AM-009
Event Information
Poster Board
PS03-08AM-009
Poster
View posterAbstract
Oligoclonal band (OCB) profiles are central to the diagnostic evaluation of early multiple sclerosis (MS). OCB Type 2 reflects intrathecal IgG synthesis, whereas Type 1 indicates immunological inactivity. Whether these immunological differences are reflected in peripheral serum metabolism remains unclear. Identifying metabolic correlates of early immune activation may support the development of minimally invasive biomarkers complementary to cerebrospinal fluid (CSF) analysis.
Archived serum samples from patients evaluated for suspected central nervous system inflammatory disease were analyzed using quantitative 1H-NMR spectroscopy. OCB Type 1 (n = 24) and OCB Type 2 (n = 25) groups were compared. Metabolites were quantified using Chenomx software. Statistical analyses included non-parametric group comparisons, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), variable importance in projection (VIP) scoring, and receiver operating characteristic (ROC) analyses.
OCB Type 1 and Type 2 patients exhibited distinct serum metabolic profiles. Amino acid–related metabolites showed the most pronounced differences, with leucine, histidine, and glycine significantly differing between groups (p < 0.05). Multivariate analyses supported these findings: PLS-DA demonstrated separation between groups, key metabolites showed elevated VIP scores (>1.0), and ROC analyses indicated good discriminatory performance. Unsupervised PCA revealed a trend toward group separation consistent with OCB status.
Serum 1H-NMR metabolomic profiling differentiates OCB Type 1 and Type 2 patterns, indicating that intrathecal immune status is associated with measurable peripheral metabolic differences. These findings support the potential role of serum metabolites as minimally invasive biomarkers to complement CSF-based diagnostics in early MS.
Archived serum samples from patients evaluated for suspected central nervous system inflammatory disease were analyzed using quantitative 1H-NMR spectroscopy. OCB Type 1 (n = 24) and OCB Type 2 (n = 25) groups were compared. Metabolites were quantified using Chenomx software. Statistical analyses included non-parametric group comparisons, principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), variable importance in projection (VIP) scoring, and receiver operating characteristic (ROC) analyses.
OCB Type 1 and Type 2 patients exhibited distinct serum metabolic profiles. Amino acid–related metabolites showed the most pronounced differences, with leucine, histidine, and glycine significantly differing between groups (p < 0.05). Multivariate analyses supported these findings: PLS-DA demonstrated separation between groups, key metabolites showed elevated VIP scores (>1.0), and ROC analyses indicated good discriminatory performance. Unsupervised PCA revealed a trend toward group separation consistent with OCB status.
Serum 1H-NMR metabolomic profiling differentiates OCB Type 1 and Type 2 patterns, indicating that intrathecal immune status is associated with measurable peripheral metabolic differences. These findings support the potential role of serum metabolites as minimally invasive biomarkers to complement CSF-based diagnostics in early MS.
Recommended posters
SPATIAL METABOLOMICS REVEALS REGION-SPECIFIC METABOLIC ALTERATIONS IN PROGRESSIVE MULTIPLE SCLEROSIS
Esposito Riccardo, Annamaria Finardi, Zulkifal Malik, Alessia Amenta, Roberto Furlan, Giuseppe Martano, Francesco Bifari
BLOOD COUNT-DERIVED INFLAMMATORY BIOMARKERS AND NEUROCOGNITIVE PERFORMANCE IN RELAPSING REMITTING MULTIPLE SCLEROSIS: A PROSPECTIVE PILOT STUDY
Andros Vazquez Montero, Graciela Agar Cárdenas Hernández, Edda Lydia Sciutto Conde, Gladis Del Carmen Fragoso González
METABOLOMIC AND PROTEOMIC PROFILING REVEAL RECOVERY-RELATED SERUM SIGNATURES IN SPINAL CORD INJURY PATIENTS UNDER REHABILITATION
Barbara M de Sousa, Marisa Costa, Fernando García, Abida Islam Pranty, Javier Muñoz, Fátima Gandarez, James Adjaye, Alexandra Nunes, Maria Ribeiro-Cunha, Sandra I. Vieira
ANTIBODY FC GLYCAN SIGNATURES TRACK WITH COMPARTMENTS, ETIOLOGY AND ONE-YEAR OUTCOMES IN ANTI-NMDA RECEPTOR ENCEPHALITIS
Giulia Cicalese, Laura Marmolejo, Alice Taddeucci, Claudia Papi, Chiara Milano, Esther Aguilar, Estibaliz Maudes, Ivana Duvnjak Orešković, Jerko Štambuk, Maja Pučić Baković, Gemma Olivé-Cirera, Mar Guasp, Eugenia Martinez-Hernandez, Thais Armangué, Josep Dalmau, Marianna Spatola
MULTIMODAL MRI AND METABOLOMICS REVEAL NEUROPROTECTIVE EFFECTS OF NLRP3 INFLAMMASOME INHIBITION IN A PROGRESSIVE MOUSE MODEL OF MULTIPLE SCLEROSIS
Nemat Khan, Abdullah Althobity, Vinod Kumar, Gary Cowin, Ian Brereton, Nyoman Kurniawan, Trent Woodruff
D-SERINE REFLECTS INTRATHECAL INFLAMMATION IN MULTIPLE SCLEROSIS AND COUNTERACTS MOTOR IMPAIRMENT IN A MURINE MODEL
Alessandro Usiello, Kenta Arisumi, Tommaso Nuzzo, Luana Gilio, Sakiko Taniguchi, Rosita Russo, Haruhiko Motegi, Raffaella di Vito, Junichi Hata, Francesco Errico, Akinori Hashiguchi, Hideyuki Okano, Roberto Furlan, Annamaria Finardi, Mario Stampanoni Bassi, Jin Nakahara, Masashi Mita, Takanori Kanai, Angela Chambery, Masato Yasui, Diego Centonze, Jumpei Sasabe